Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke
- 1 November 1997
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 131 (5) , 757-760
- https://doi.org/10.1016/s0022-3476(97)70108-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Hydroxyurea: An alternative to transfusion therapy for stroke in sickle cell anemiaAmerican Journal of Hematology, 1995
- Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusionsThe Journal of Pediatrics, 1995
- High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell diseaseThe Journal of Pediatrics, 1991
- Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell diseaseBlood, 1984
- Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidentsThe Journal of Pediatrics, 1980
- The natural history of stroke in sickle cell diseaseThe American Journal of Medicine, 1978